Pacheco MacLeod

The identified DEGs were mainly involved in carbohydrate binding, Kawasaki disease, atherosclerosis, and arteriosclerotic cardiovascular disease. Gene sets related to atherosclerosis signaling, primary immunodeficiency, IL-17, and TNF signaling pathways were differentially activated in AMI compared with the control. IL1R2, IRAK3, and THBD were…[Read more]

The primary reason to use vitamin D in kidney disease remains to lower PTH levels.PURPOSE OF REVIEW People with chronic kidney disease have a high prevalence of poor physical function, which in turn is associated with poor health-related quality of life, and an increased risk of adverse events, including hospitalizations and all-cause mortality.…[Read more]

The primary reason to use vitamin D in kidney disease remains to lower PTH levels.PURPOSE OF REVIEW People with chronic kidney disease have a high prevalence of poor physical function, which in turn is associated with poor health-related quality of life, and an increased risk of adverse events, including hospitalizations and all-cause mortality.…[Read more]

The primary reason to use vitamin D in kidney disease remains to lower PTH levels.PURPOSE OF REVIEW People with chronic kidney disease have a high prevalence of poor physical function, which in turn is associated with poor health-related quality of life, and an increased risk of adverse events, including hospitalizations and all-cause mortality.…[Read more]